CARFILZOMIB AND DEXAMETHASONE VS SUBCUTANEOUS BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SECONDARY ANALYSIS FROM THE PHASE 3 STUDY ENDEAVOR (NCT01568866)H. Goldschmidt,P. Moreau,A. Palumbo, U. Joshua,L. Pour,R. Hajek,T. Facon,H. Ludwig,R. Niesvizky,A. Oriol, L. Rosinol,J. Straub,A. Suvorov,C. Araujo, E. Rimashevskaya,T. Pika, G. Gaidano,K. Weisel, V. Goronova-Marinova,A. Schwarer, L. Minuk,T. Masszi, I. Karamanesht,M. Offidani,V. Hungria,A. Spencer,R. Orlowski, K. Iskander,S. Feng,S. Aggarwal,W. J. Chng,Ma DimopoulosHAEMATOLOGICA（2016）引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
